US Broker Ratings

Absci Corporation (ABSI)

⚠️ No article content returned.

..

CytomX Therapeutics, Inc. (CTMX) Stock Analysis: Exploring a Potential 340% Upside in the Biotech Sector

For investors seeking high-risk, high-reward opportunities in the biotechnology sector, CytomX Therapeutics, Inc. (NASDAQ: CTMX) presents a compelling case. With a market capitalization of $605.76 million, CytomX is carving its..

TotalEnergies SE (TTE) Stock Analysis: Exploring the 5.49% Upside Potential and Robust Dividend Yield

TotalEnergies SE (NYSE: TTE), one of the world’s leading integrated energy companies, stands as a formidable player in the oil and gas sector. With a market capitalization of $202.5 billion..

Benitec Biopharma Inc. (BNTC): Analyst Ratings Signal 147% Potential Upside

Benitec Biopharma Inc. (NASDAQ: BNTC), a clinical-stage biotechnology company, is capturing investor attention with its innovative approach to genetic medicine and compelling analyst ratings. With a market capitalization of $342.9..

Olema Pharmaceuticals, Inc. (OLMA): A Biotech Stock with 313% Upside Potential Draws Attention

Investors seeking exposure in the healthcare sector, particularly in the booming field of biotechnology, might find Olema Pharmaceuticals, Inc. (NASDAQ: OLMA) an intriguing opportunity. With a market capitalization of $772.6..

Zhengye Biotechnology Holding (ZYBT) Stock Analysis: Navigating Challenges in a Volatile Market

Zhengye Biotechnology Holding Limited (ZYBT) is a Chinese company operating in the healthcare sector, specifically within the drug manufacturers’ niche for specialty and generic products. Despite its focus on a..

Integra LifeSciences Holdings (IART) Stock Analysis: Potential 25% Upside Amid Market Challenges

Integra LifeSciences Holdings Corporation (NASDAQ: IART), a prominent player in the healthcare sector, focuses on delivering innovative medical devices that serve critical needs in neurosurgery, wound care, and ear, nose,..

MiMedx Group, Inc (MDXG) Stock Analysis: Exploring a 53.85% Potential Upside in Biotechnology

MiMedx Group, Inc. (NASDAQ: MDXG), a prominent player in the biotechnology sector, is drawing attention from investors with a remarkable potential upside of 53.85%. Based in Marietta, Georgia, MiMedx specializes..

Pediatrix Medical Group, Inc. (MD) Stock Analysis: Navigating Growth in Healthcare with a 20.39% Return on Equity

Pediatrix Medical Group, Inc. (NYSE: MD), a key player in the healthcare sector, specializes in providing comprehensive care for newborns, expectant mothers, and other pediatric subspecialties in the United States...

Aveanna Healthcare Holdings Inc (AVAH) Stock Analysis: Unpacking a 198% Return on Equity and Growth Prospects

Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH) is a compelling player in the healthcare sector, specifically within the medical care facilities industry. With its headquarters in Atlanta, Georgia, Aveanna is a..

Pulse Biosciences, Inc (PLSE) Stock Analysis: A Healthcare Innovator with Strong Buy Ratings Amidst Volatile Market Conditions

Pulse Biosciences, Inc (NASDAQ: PLSE) is making waves in the healthcare sector with its innovative bioelectric medicine technologies. Headquartered in Miami, Florida, the company is a key player in the..

MannKind Corporation (MNKD) Stock Analysis: Exploring a 127.68% Potential Upside in the Biotech Space

Investors with a focus on the biotechnology sector may find MannKind Corporation (NASDAQ: MNKD) an intriguing prospect, with its robust pipeline targeting unmet medical needs and a remarkable 127.68% potential..

Guardian Pharmacy Services, Inc (GRDN) Stock Analysis: Strong Buy Ratings Signal Upside Potential

Guardian Pharmacy Services, Inc (GRDN), a leader in providing technology-driven pharmacy services to long-term care facilities (LTCFs) across the United States, is generating significant investor interest. With a market capitalization..

Arcutis Biotherapeutics (ARQT) Stock Analysis: A 42.53% Potential Upside Ignites Investor Interest

Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT), a burgeoning player in the biotechnology sector, is capturing investor attention with its robust growth prospects and a noteworthy potential upside of 42.53%. With a..

BioLife Solutions, Inc. (BLFS) Stock Analysis: Navigating Healthcare Innovation with Upside Potential

BioLife Solutions, Inc. (NASDAQ: BLFS), a key player in the healthcare sector specializing in medical instruments and supplies, has been making waves with its innovative solutions for the cell and..

Harrow, Inc. (HROW) Stock Analysis: Unveiling a 91.63% Potential Upside in the Eyecare Pharmaceutical Sector

Harrow, Inc. (NASDAQ: HROW) is making waves in the healthcare sector, particularly within the niche of specialty and generic drug manufacturing. Focused on the ophthalmic pharmaceutical market, Harrow is poised..

NeoGenomics, Inc. (NEO) Stock Analysis: Strong Buy Ratings Amid 11.2% Revenue Growth

NeoGenomics, Inc. (NASDAQ: NEO) stands out as a compelling opportunity within the diagnostics and research industry, particularly for investors keen on the healthcare sector. With a market capitalization of $2.53..

U.S. Physical Therapy, Inc. (USPH) Stock Analysis: 17.65% Potential Upside Captures Investor Attention

With a market capitalization of $1.23 billion, U.S. Physical Therapy, Inc. (NYSE: USPH) stands as a notable player in the healthcare sector, specifically within the medical care facilities industry. Based..

Agios Pharmaceuticals, Inc. (AGIO) Investor Outlook: A 36% Upside Potential Amidst Robust Revenue Growth

Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) presents an intriguing opportunity within the healthcare sector, particularly in the biotechnology industry, where its innovative approach to cellular metabolism could drive future growth. Headquartered..

Innoviva, Inc. (INVA) Stock Analysis: Exploring a 66.35% Potential Upside in the Biotech Space

Innoviva, Inc. (NASDAQ: INVA) is an intriguing player in the biotech industry that offers a compelling investment opportunity with a potential upside of 66.35%, according to the average analyst target..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds